Lv52
1430 积分 2024-08-10 加入
A novel therapy targeting the gut–liver axis for chronic hepatitis B: ursodesoxycholic acid plus Bifidobacterium
12天前
已关闭
A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort
14天前
已完结
A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B
14天前
已完结
Developing and validating clinical prediction models in hepatology – An overview for clinicians
30天前
已完结
An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
1个月前
已完结
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
1个月前
已完结
Interleukin-17 in Liver Disease Pathogenesis
2个月前
已完结
The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms
2个月前
已完结
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
3个月前
已完结
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
4个月前
已完结
皖公网安备34019202002308
